Global Influenza Subunit Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Influenza subunit vaccine is a type of vaccine used to prevent influenza. It contains specific protein subunits of the influenza virus, usually the influenza virus hemagglutinin and neuraminidase. These subunits stimulate the body's immune system to produce antibodies that provide protection when infected with the influenza virus.
The global Influenza Subunit Vaccine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Influenza Subunit Vaccine Industry Forecast” looks at past sales and reviews total world Influenza Subunit Vaccine sales in 2023, providing a comprehensive analysis by region and market sector of projected Influenza Subunit Vaccine sales for 2024 through 2030. With Influenza Subunit Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Influenza Subunit Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Influenza Subunit Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Influenza Subunit Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Influenza Subunit Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Influenza Subunit Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Influenza Subunit Vaccine.
United States market for Influenza Subunit Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Influenza Subunit Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Influenza Subunit Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Influenza Subunit Vaccine players cover Ab&B BIO-TECH, Sanofi, Seqirus, Inc, Zhongyianke Biology, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Subunit Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Influenza Subunit Vaccine market?
What factors are driving Influenza Subunit Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Influenza Subunit Vaccine market opportunities vary by end market size?
How does Influenza Subunit Vaccine break out by Type, by Application?
Influenza subunit vaccine is a type of vaccine used to prevent influenza. It contains specific protein subunits of the influenza virus, usually the influenza virus hemagglutinin and neuraminidase. These subunits stimulate the body's immune system to produce antibodies that provide protection when infected with the influenza virus.
The global Influenza Subunit Vaccine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Influenza Subunit Vaccine Industry Forecast” looks at past sales and reviews total world Influenza Subunit Vaccine sales in 2023, providing a comprehensive analysis by region and market sector of projected Influenza Subunit Vaccine sales for 2024 through 2030. With Influenza Subunit Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Influenza Subunit Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Influenza Subunit Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Influenza Subunit Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Influenza Subunit Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Influenza Subunit Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Influenza Subunit Vaccine.
United States market for Influenza Subunit Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Influenza Subunit Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Influenza Subunit Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Influenza Subunit Vaccine players cover Ab&B BIO-TECH, Sanofi, Seqirus, Inc, Zhongyianke Biology, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Subunit Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Trivalent Vaccines
- Tetravalent Vaccine
- Aldult
- Child
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ab&B BIO-TECH
- Sanofi
- Seqirus, Inc
- Zhongyianke Biology
What is the 10-year outlook for the global Influenza Subunit Vaccine market?
What factors are driving Influenza Subunit Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Influenza Subunit Vaccine market opportunities vary by end market size?
How does Influenza Subunit Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza Subunit Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Influenza Subunit Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Influenza Subunit Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Influenza Subunit Vaccine Segment by Type
2.2.1 Trivalent Vaccines
2.2.2 Tetravalent Vaccine
2.3 Influenza Subunit Vaccine Sales by Type
2.3.1 Global Influenza Subunit Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Influenza Subunit Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Influenza Subunit Vaccine Sale Price by Type (2019-2024)
2.4 Influenza Subunit Vaccine Segment by Application
2.4.1 Aldult
2.4.2 Child
2.5 Influenza Subunit Vaccine Sales by Application
2.5.1 Global Influenza Subunit Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Influenza Subunit Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Influenza Subunit Vaccine Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Influenza Subunit Vaccine Breakdown Data by Company
3.1.1 Global Influenza Subunit Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Influenza Subunit Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Influenza Subunit Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Influenza Subunit Vaccine Revenue by Company (2019-2024)
3.2.2 Global Influenza Subunit Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Influenza Subunit Vaccine Sale Price by Company
3.4 Key Manufacturers Influenza Subunit Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Influenza Subunit Vaccine Product Location Distribution
3.4.2 Players Influenza Subunit Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INFLUENZA SUBUNIT VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Influenza Subunit Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Influenza Subunit Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Influenza Subunit Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Influenza Subunit Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Influenza Subunit Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Influenza Subunit Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Influenza Subunit Vaccine Sales Growth
4.4 APAC Influenza Subunit Vaccine Sales Growth
4.5 Europe Influenza Subunit Vaccine Sales Growth
4.6 Middle East & Africa Influenza Subunit Vaccine Sales Growth
5 AMERICAS
5.1 Americas Influenza Subunit Vaccine Sales by Country
5.1.1 Americas Influenza Subunit Vaccine Sales by Country (2019-2024)
5.1.2 Americas Influenza Subunit Vaccine Revenue by Country (2019-2024)
5.2 Americas Influenza Subunit Vaccine Sales by Type (2019-2024)
5.3 Americas Influenza Subunit Vaccine Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza Subunit Vaccine Sales by Region
6.1.1 APAC Influenza Subunit Vaccine Sales by Region (2019-2024)
6.1.2 APAC Influenza Subunit Vaccine Revenue by Region (2019-2024)
6.2 APAC Influenza Subunit Vaccine Sales by Type (2019-2024)
6.3 APAC Influenza Subunit Vaccine Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Influenza Subunit Vaccine by Country
7.1.1 Europe Influenza Subunit Vaccine Sales by Country (2019-2024)
7.1.2 Europe Influenza Subunit Vaccine Revenue by Country (2019-2024)
7.2 Europe Influenza Subunit Vaccine Sales by Type (2019-2024)
7.3 Europe Influenza Subunit Vaccine Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza Subunit Vaccine by Country
8.1.1 Middle East & Africa Influenza Subunit Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Influenza Subunit Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Influenza Subunit Vaccine Sales by Type (2019-2024)
8.3 Middle East & Africa Influenza Subunit Vaccine Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Influenza Subunit Vaccine
10.3 Manufacturing Process Analysis of Influenza Subunit Vaccine
10.4 Industry Chain Structure of Influenza Subunit Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Influenza Subunit Vaccine Distributors
11.3 Influenza Subunit Vaccine Customer
12 WORLD FORECAST REVIEW FOR INFLUENZA SUBUNIT VACCINE BY GEOGRAPHIC REGION
12.1 Global Influenza Subunit Vaccine Market Size Forecast by Region
12.1.1 Global Influenza Subunit Vaccine Forecast by Region (2025-2030)
12.1.2 Global Influenza Subunit Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Influenza Subunit Vaccine Forecast by Type (2025-2030)
12.7 Global Influenza Subunit Vaccine Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Ab&B BIO-TECH
13.1.1 Ab&B BIO-TECH Company Information
13.1.2 Ab&B BIO-TECH Influenza Subunit Vaccine Product Portfolios and Specifications
13.1.3 Ab&B BIO-TECH Influenza Subunit Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Ab&B BIO-TECH Main Business Overview
13.1.5 Ab&B BIO-TECH Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Influenza Subunit Vaccine Product Portfolios and Specifications
13.2.3 Sanofi Influenza Subunit Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Seqirus, Inc
13.3.1 Seqirus, Inc Company Information
13.3.2 Seqirus, Inc Influenza Subunit Vaccine Product Portfolios and Specifications
13.3.3 Seqirus, Inc Influenza Subunit Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Seqirus, Inc Main Business Overview
13.3.5 Seqirus, Inc Latest Developments
13.4 Zhongyianke Biology
13.4.1 Zhongyianke Biology Company Information
13.4.2 Zhongyianke Biology Influenza Subunit Vaccine Product Portfolios and Specifications
13.4.3 Zhongyianke Biology Influenza Subunit Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Zhongyianke Biology Main Business Overview
13.4.5 Zhongyianke Biology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza Subunit Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Influenza Subunit Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Influenza Subunit Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Influenza Subunit Vaccine Segment by Type
2.2.1 Trivalent Vaccines
2.2.2 Tetravalent Vaccine
2.3 Influenza Subunit Vaccine Sales by Type
2.3.1 Global Influenza Subunit Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Influenza Subunit Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Influenza Subunit Vaccine Sale Price by Type (2019-2024)
2.4 Influenza Subunit Vaccine Segment by Application
2.4.1 Aldult
2.4.2 Child
2.5 Influenza Subunit Vaccine Sales by Application
2.5.1 Global Influenza Subunit Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Influenza Subunit Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Influenza Subunit Vaccine Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Influenza Subunit Vaccine Breakdown Data by Company
3.1.1 Global Influenza Subunit Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Influenza Subunit Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Influenza Subunit Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Influenza Subunit Vaccine Revenue by Company (2019-2024)
3.2.2 Global Influenza Subunit Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Influenza Subunit Vaccine Sale Price by Company
3.4 Key Manufacturers Influenza Subunit Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Influenza Subunit Vaccine Product Location Distribution
3.4.2 Players Influenza Subunit Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INFLUENZA SUBUNIT VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Influenza Subunit Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Influenza Subunit Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Influenza Subunit Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Influenza Subunit Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Influenza Subunit Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Influenza Subunit Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Influenza Subunit Vaccine Sales Growth
4.4 APAC Influenza Subunit Vaccine Sales Growth
4.5 Europe Influenza Subunit Vaccine Sales Growth
4.6 Middle East & Africa Influenza Subunit Vaccine Sales Growth
5 AMERICAS
5.1 Americas Influenza Subunit Vaccine Sales by Country
5.1.1 Americas Influenza Subunit Vaccine Sales by Country (2019-2024)
5.1.2 Americas Influenza Subunit Vaccine Revenue by Country (2019-2024)
5.2 Americas Influenza Subunit Vaccine Sales by Type (2019-2024)
5.3 Americas Influenza Subunit Vaccine Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza Subunit Vaccine Sales by Region
6.1.1 APAC Influenza Subunit Vaccine Sales by Region (2019-2024)
6.1.2 APAC Influenza Subunit Vaccine Revenue by Region (2019-2024)
6.2 APAC Influenza Subunit Vaccine Sales by Type (2019-2024)
6.3 APAC Influenza Subunit Vaccine Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Influenza Subunit Vaccine by Country
7.1.1 Europe Influenza Subunit Vaccine Sales by Country (2019-2024)
7.1.2 Europe Influenza Subunit Vaccine Revenue by Country (2019-2024)
7.2 Europe Influenza Subunit Vaccine Sales by Type (2019-2024)
7.3 Europe Influenza Subunit Vaccine Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza Subunit Vaccine by Country
8.1.1 Middle East & Africa Influenza Subunit Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Influenza Subunit Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Influenza Subunit Vaccine Sales by Type (2019-2024)
8.3 Middle East & Africa Influenza Subunit Vaccine Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Influenza Subunit Vaccine
10.3 Manufacturing Process Analysis of Influenza Subunit Vaccine
10.4 Industry Chain Structure of Influenza Subunit Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Influenza Subunit Vaccine Distributors
11.3 Influenza Subunit Vaccine Customer
12 WORLD FORECAST REVIEW FOR INFLUENZA SUBUNIT VACCINE BY GEOGRAPHIC REGION
12.1 Global Influenza Subunit Vaccine Market Size Forecast by Region
12.1.1 Global Influenza Subunit Vaccine Forecast by Region (2025-2030)
12.1.2 Global Influenza Subunit Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Influenza Subunit Vaccine Forecast by Type (2025-2030)
12.7 Global Influenza Subunit Vaccine Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Ab&B BIO-TECH
13.1.1 Ab&B BIO-TECH Company Information
13.1.2 Ab&B BIO-TECH Influenza Subunit Vaccine Product Portfolios and Specifications
13.1.3 Ab&B BIO-TECH Influenza Subunit Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Ab&B BIO-TECH Main Business Overview
13.1.5 Ab&B BIO-TECH Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Influenza Subunit Vaccine Product Portfolios and Specifications
13.2.3 Sanofi Influenza Subunit Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Seqirus, Inc
13.3.1 Seqirus, Inc Company Information
13.3.2 Seqirus, Inc Influenza Subunit Vaccine Product Portfolios and Specifications
13.3.3 Seqirus, Inc Influenza Subunit Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Seqirus, Inc Main Business Overview
13.3.5 Seqirus, Inc Latest Developments
13.4 Zhongyianke Biology
13.4.1 Zhongyianke Biology Company Information
13.4.2 Zhongyianke Biology Influenza Subunit Vaccine Product Portfolios and Specifications
13.4.3 Zhongyianke Biology Influenza Subunit Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Zhongyianke Biology Main Business Overview
13.4.5 Zhongyianke Biology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Influenza Subunit Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Influenza Subunit Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Trivalent Vaccines
Table 4. Major Players of Tetravalent Vaccine
Table 5. Global Influenza Subunit Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global Influenza Subunit Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Influenza Subunit Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Influenza Subunit Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Influenza Subunit Vaccine Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Influenza Subunit Vaccine Sale by Application (2019-2024) & (K Units)
Table 11. Global Influenza Subunit Vaccine Sale Market Share by Application (2019-2024)
Table 12. Global Influenza Subunit Vaccine Revenue by Application (2019-2024) & ($ million)
Table 13. Global Influenza Subunit Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Influenza Subunit Vaccine Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Influenza Subunit Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global Influenza Subunit Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Influenza Subunit Vaccine Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Influenza Subunit Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Influenza Subunit Vaccine Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Influenza Subunit Vaccine Producing Area Distribution and Sales Area
Table 21. Players Influenza Subunit Vaccine Products Offered
Table 22. Influenza Subunit Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Influenza Subunit Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Influenza Subunit Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Influenza Subunit Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Influenza Subunit Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Influenza Subunit Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Influenza Subunit Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Influenza Subunit Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Influenza Subunit Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Influenza Subunit Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas Influenza Subunit Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Influenza Subunit Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Influenza Subunit Vaccine Sales by Type (2019-2024) & (K Units)
Table 37. Americas Influenza Subunit Vaccine Sales by Application (2019-2024) & (K Units)
Table 38. APAC Influenza Subunit Vaccine Sales by Region (2019-2024) & (K Units)
Table 39. APAC Influenza Subunit Vaccine Sales Market Share by Region (2019-2024)
Table 40. APAC Influenza Subunit Vaccine Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Influenza Subunit Vaccine Sales by Type (2019-2024) & (K Units)
Table 42. APAC Influenza Subunit Vaccine Sales by Application (2019-2024) & (K Units)
Table 43. Europe Influenza Subunit Vaccine Sales by Country (2019-2024) & (K Units)
Table 44. Europe Influenza Subunit Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Influenza Subunit Vaccine Sales by Type (2019-2024) & (K Units)
Table 46. Europe Influenza Subunit Vaccine Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa Influenza Subunit Vaccine Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa Influenza Subunit Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Influenza Subunit Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Middle East & Africa Influenza Subunit Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Influenza Subunit Vaccine
Table 52. Key Market Challenges & Risks of Influenza Subunit Vaccine
Table 53. Key Industry Trends of Influenza Subunit Vaccine
Table 54. Influenza Subunit Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Influenza Subunit Vaccine Distributors List
Table 57. Influenza Subunit Vaccine Customer List
Table 58. Global Influenza Subunit Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 59. Global Influenza Subunit Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Influenza Subunit Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 61. Americas Influenza Subunit Vaccine Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Influenza Subunit Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 63. APAC Influenza Subunit Vaccine Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Influenza Subunit Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Europe Influenza Subunit Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Influenza Subunit Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa Influenza Subunit Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Influenza Subunit Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 69. Global Influenza Subunit Vaccine Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Influenza Subunit Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 71. Global Influenza Subunit Vaccine Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Ab&B BIO-TECH Basic Information, Influenza Subunit Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Ab&B BIO-TECH Influenza Subunit Vaccine Product Portfolios and Specifications
Table 74. Ab&B BIO-TECH Influenza Subunit Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Ab&B BIO-TECH Main Business
Table 76. Ab&B BIO-TECH Latest Developments
Table 77. Sanofi Basic Information, Influenza Subunit Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Sanofi Influenza Subunit Vaccine Product Portfolios and Specifications
Table 79. Sanofi Influenza Subunit Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Sanofi Main Business
Table 81. Sanofi Latest Developments
Table 82. Seqirus, Inc Basic Information, Influenza Subunit Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Seqirus, Inc Influenza Subunit Vaccine Product Portfolios and Specifications
Table 84. Seqirus, Inc Influenza Subunit Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Seqirus, Inc Main Business
Table 86. Seqirus, Inc Latest Developments
Table 87. Zhongyianke Biology Basic Information, Influenza Subunit Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Zhongyianke Biology Influenza Subunit Vaccine Product Portfolios and Specifications
Table 89. Zhongyianke Biology Influenza Subunit Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Zhongyianke Biology Main Business
Table 91. Zhongyianke Biology Latest Developments
Table 1. Influenza Subunit Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Influenza Subunit Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Trivalent Vaccines
Table 4. Major Players of Tetravalent Vaccine
Table 5. Global Influenza Subunit Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global Influenza Subunit Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Influenza Subunit Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Influenza Subunit Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Influenza Subunit Vaccine Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Influenza Subunit Vaccine Sale by Application (2019-2024) & (K Units)
Table 11. Global Influenza Subunit Vaccine Sale Market Share by Application (2019-2024)
Table 12. Global Influenza Subunit Vaccine Revenue by Application (2019-2024) & ($ million)
Table 13. Global Influenza Subunit Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Influenza Subunit Vaccine Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Influenza Subunit Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global Influenza Subunit Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Influenza Subunit Vaccine Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Influenza Subunit Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Influenza Subunit Vaccine Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Influenza Subunit Vaccine Producing Area Distribution and Sales Area
Table 21. Players Influenza Subunit Vaccine Products Offered
Table 22. Influenza Subunit Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Influenza Subunit Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Influenza Subunit Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Influenza Subunit Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Influenza Subunit Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Influenza Subunit Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Influenza Subunit Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Influenza Subunit Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Influenza Subunit Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Influenza Subunit Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas Influenza Subunit Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Influenza Subunit Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Influenza Subunit Vaccine Sales by Type (2019-2024) & (K Units)
Table 37. Americas Influenza Subunit Vaccine Sales by Application (2019-2024) & (K Units)
Table 38. APAC Influenza Subunit Vaccine Sales by Region (2019-2024) & (K Units)
Table 39. APAC Influenza Subunit Vaccine Sales Market Share by Region (2019-2024)
Table 40. APAC Influenza Subunit Vaccine Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Influenza Subunit Vaccine Sales by Type (2019-2024) & (K Units)
Table 42. APAC Influenza Subunit Vaccine Sales by Application (2019-2024) & (K Units)
Table 43. Europe Influenza Subunit Vaccine Sales by Country (2019-2024) & (K Units)
Table 44. Europe Influenza Subunit Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Influenza Subunit Vaccine Sales by Type (2019-2024) & (K Units)
Table 46. Europe Influenza Subunit Vaccine Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa Influenza Subunit Vaccine Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa Influenza Subunit Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Influenza Subunit Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Middle East & Africa Influenza Subunit Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Influenza Subunit Vaccine
Table 52. Key Market Challenges & Risks of Influenza Subunit Vaccine
Table 53. Key Industry Trends of Influenza Subunit Vaccine
Table 54. Influenza Subunit Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Influenza Subunit Vaccine Distributors List
Table 57. Influenza Subunit Vaccine Customer List
Table 58. Global Influenza Subunit Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 59. Global Influenza Subunit Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Influenza Subunit Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 61. Americas Influenza Subunit Vaccine Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Influenza Subunit Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 63. APAC Influenza Subunit Vaccine Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Influenza Subunit Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Europe Influenza Subunit Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Influenza Subunit Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa Influenza Subunit Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Influenza Subunit Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 69. Global Influenza Subunit Vaccine Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Influenza Subunit Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 71. Global Influenza Subunit Vaccine Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Ab&B BIO-TECH Basic Information, Influenza Subunit Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Ab&B BIO-TECH Influenza Subunit Vaccine Product Portfolios and Specifications
Table 74. Ab&B BIO-TECH Influenza Subunit Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Ab&B BIO-TECH Main Business
Table 76. Ab&B BIO-TECH Latest Developments
Table 77. Sanofi Basic Information, Influenza Subunit Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Sanofi Influenza Subunit Vaccine Product Portfolios and Specifications
Table 79. Sanofi Influenza Subunit Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Sanofi Main Business
Table 81. Sanofi Latest Developments
Table 82. Seqirus, Inc Basic Information, Influenza Subunit Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Seqirus, Inc Influenza Subunit Vaccine Product Portfolios and Specifications
Table 84. Seqirus, Inc Influenza Subunit Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Seqirus, Inc Main Business
Table 86. Seqirus, Inc Latest Developments
Table 87. Zhongyianke Biology Basic Information, Influenza Subunit Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Zhongyianke Biology Influenza Subunit Vaccine Product Portfolios and Specifications
Table 89. Zhongyianke Biology Influenza Subunit Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Zhongyianke Biology Main Business
Table 91. Zhongyianke Biology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Influenza Subunit Vaccine
Figure 2. Influenza Subunit Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Influenza Subunit Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Influenza Subunit Vaccine Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Influenza Subunit Vaccine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Influenza Subunit Vaccine Sales Market Share by Country/Region (2023)
Figure 10. Influenza Subunit Vaccine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Trivalent Vaccines
Figure 12. Product Picture of Tetravalent Vaccine
Figure 13. Global Influenza Subunit Vaccine Sales Market Share by Type in 2023
Figure 14. Global Influenza Subunit Vaccine Revenue Market Share by Type (2019-2024)
Figure 15. Influenza Subunit Vaccine Consumed in Aldult
Figure 16. Global Influenza Subunit Vaccine Market: Aldult (2019-2024) & (K Units)
Figure 17. Influenza Subunit Vaccine Consumed in Child
Figure 18. Global Influenza Subunit Vaccine Market: Child (2019-2024) & (K Units)
Figure 19. Global Influenza Subunit Vaccine Sale Market Share by Application (2023)
Figure 20. Global Influenza Subunit Vaccine Revenue Market Share by Application in 2023
Figure 21. Influenza Subunit Vaccine Sales by Company in 2023 (K Units)
Figure 22. Global Influenza Subunit Vaccine Sales Market Share by Company in 2023
Figure 23. Influenza Subunit Vaccine Revenue by Company in 2023 ($ millions)
Figure 24. Global Influenza Subunit Vaccine Revenue Market Share by Company in 2023
Figure 25. Global Influenza Subunit Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Influenza Subunit Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Influenza Subunit Vaccine Sales 2019-2024 (K Units)
Figure 28. Americas Influenza Subunit Vaccine Revenue 2019-2024 ($ millions)
Figure 29. APAC Influenza Subunit Vaccine Sales 2019-2024 (K Units)
Figure 30. APAC Influenza Subunit Vaccine Revenue 2019-2024 ($ millions)
Figure 31. Europe Influenza Subunit Vaccine Sales 2019-2024 (K Units)
Figure 32. Europe Influenza Subunit Vaccine Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa Influenza Subunit Vaccine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Influenza Subunit Vaccine Revenue 2019-2024 ($ millions)
Figure 35. Americas Influenza Subunit Vaccine Sales Market Share by Country in 2023
Figure 36. Americas Influenza Subunit Vaccine Revenue Market Share by Country (2019-2024)
Figure 37. Americas Influenza Subunit Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas Influenza Subunit Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC Influenza Subunit Vaccine Sales Market Share by Region in 2023
Figure 44. APAC Influenza Subunit Vaccine Revenue Market Share by Region (2019-2024)
Figure 45. APAC Influenza Subunit Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC Influenza Subunit Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 51. India Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 53. China Taiwan Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe Influenza Subunit Vaccine Sales Market Share by Country in 2023
Figure 55. Europe Influenza Subunit Vaccine Revenue Market Share by Country (2019-2024)
Figure 56. Europe Influenza Subunit Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe Influenza Subunit Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 59. France Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 60. UK Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa Influenza Subunit Vaccine Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa Influenza Subunit Vaccine Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Influenza Subunit Vaccine Sales Market Share by Application (2019-2024)
Figure 66. Egypt Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 69. Turkey Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Influenza Subunit Vaccine in 2023
Figure 72. Manufacturing Process Analysis of Influenza Subunit Vaccine
Figure 73. Industry Chain Structure of Influenza Subunit Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Influenza Subunit Vaccine Sales Market Forecast by Region (2025-2030)
Figure 76. Global Influenza Subunit Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Influenza Subunit Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Influenza Subunit Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Influenza Subunit Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Influenza Subunit Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Influenza Subunit Vaccine
Figure 2. Influenza Subunit Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Influenza Subunit Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Influenza Subunit Vaccine Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Influenza Subunit Vaccine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Influenza Subunit Vaccine Sales Market Share by Country/Region (2023)
Figure 10. Influenza Subunit Vaccine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Trivalent Vaccines
Figure 12. Product Picture of Tetravalent Vaccine
Figure 13. Global Influenza Subunit Vaccine Sales Market Share by Type in 2023
Figure 14. Global Influenza Subunit Vaccine Revenue Market Share by Type (2019-2024)
Figure 15. Influenza Subunit Vaccine Consumed in Aldult
Figure 16. Global Influenza Subunit Vaccine Market: Aldult (2019-2024) & (K Units)
Figure 17. Influenza Subunit Vaccine Consumed in Child
Figure 18. Global Influenza Subunit Vaccine Market: Child (2019-2024) & (K Units)
Figure 19. Global Influenza Subunit Vaccine Sale Market Share by Application (2023)
Figure 20. Global Influenza Subunit Vaccine Revenue Market Share by Application in 2023
Figure 21. Influenza Subunit Vaccine Sales by Company in 2023 (K Units)
Figure 22. Global Influenza Subunit Vaccine Sales Market Share by Company in 2023
Figure 23. Influenza Subunit Vaccine Revenue by Company in 2023 ($ millions)
Figure 24. Global Influenza Subunit Vaccine Revenue Market Share by Company in 2023
Figure 25. Global Influenza Subunit Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Influenza Subunit Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Influenza Subunit Vaccine Sales 2019-2024 (K Units)
Figure 28. Americas Influenza Subunit Vaccine Revenue 2019-2024 ($ millions)
Figure 29. APAC Influenza Subunit Vaccine Sales 2019-2024 (K Units)
Figure 30. APAC Influenza Subunit Vaccine Revenue 2019-2024 ($ millions)
Figure 31. Europe Influenza Subunit Vaccine Sales 2019-2024 (K Units)
Figure 32. Europe Influenza Subunit Vaccine Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa Influenza Subunit Vaccine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Influenza Subunit Vaccine Revenue 2019-2024 ($ millions)
Figure 35. Americas Influenza Subunit Vaccine Sales Market Share by Country in 2023
Figure 36. Americas Influenza Subunit Vaccine Revenue Market Share by Country (2019-2024)
Figure 37. Americas Influenza Subunit Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas Influenza Subunit Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC Influenza Subunit Vaccine Sales Market Share by Region in 2023
Figure 44. APAC Influenza Subunit Vaccine Revenue Market Share by Region (2019-2024)
Figure 45. APAC Influenza Subunit Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC Influenza Subunit Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 51. India Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 53. China Taiwan Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe Influenza Subunit Vaccine Sales Market Share by Country in 2023
Figure 55. Europe Influenza Subunit Vaccine Revenue Market Share by Country (2019-2024)
Figure 56. Europe Influenza Subunit Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe Influenza Subunit Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 59. France Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 60. UK Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa Influenza Subunit Vaccine Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa Influenza Subunit Vaccine Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Influenza Subunit Vaccine Sales Market Share by Application (2019-2024)
Figure 66. Egypt Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 69. Turkey Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Influenza Subunit Vaccine in 2023
Figure 72. Manufacturing Process Analysis of Influenza Subunit Vaccine
Figure 73. Industry Chain Structure of Influenza Subunit Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Influenza Subunit Vaccine Sales Market Forecast by Region (2025-2030)
Figure 76. Global Influenza Subunit Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Influenza Subunit Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Influenza Subunit Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Influenza Subunit Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Influenza Subunit Vaccine Revenue Market Share Forecast by Application (2025-2030)
